Cancer Genetics
Showing 9976 - 10000 of >10,000
Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- Enfortumab vedotin
-
Kansas City, KansasUniversity of Kansas Cancer Center
Jun 23, 2023
NSCLC, Metastatic Non Small Cell Lung Cancer, Nsclc Trial in United States (Local ablative therapy, Blood collection to assess
Recruiting
- Non-small Cell Lung Cancer
- +5 more
- Local ablative therapy
- Blood collection to assess for ctDNA
-
Basking Ridge, New Jersey
- +6 more
Jun 20, 2022
Ex Vivo Drug Response and Clinical Outcome in Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- Biological sample collection
-
Linz, Upper Austria, Austria
- +2 more
Sep 28, 2023
Healthy Trial in Salt Lake City (LY3537982, Digoxin, Rosuvastatin)
Not yet recruiting
- Healthy
- LY3537982
- +3 more
-
Salt Lake City, UtahICON Early Clinical & Bioanalytical Solutions
Oct 27, 2023
Cancer, Cancer Pain Trial in Bhaktapur, Kathmandu (Clinical Pharmacist Intervention)
Recruiting
- Cancer
- Cancer Pain
- Clinical Pharmacist Intervention
-
Bhaktapur, Bagmati, Nepal
- +1 more
May 4, 2022
Healthy, no Evidence of Disease, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Los Angeles (light-scattering
Terminated
- Healthy, no Evidence of Disease
- +4 more
- light-scattering spectroscopy
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Nov 11, 2021
Breast Cancer, Stage III Breast Cancer, Breast Cancer Female Trial in Boston (THRIVE, Health Education Support Program)
Not yet recruiting
- Breast Cancer
- +4 more
- THRIVE
- Health Education Support Program
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 8, 2022
Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)
Withdrawn
- Carcinoma, Non-small Cell Lung Cancer
- nivolumab
- +5 more
-
Detroit, Michigan
- +22 more
Mar 8, 2022
SCLC,Extensive Stage Trial in Changchun (AK104 IV infusion;Chiauranib oral)
Not yet recruiting
- SCLC,Extensive Stage
- AK104 IV infusion;Chiauranib oral
-
Changchun, Jilin, ChinaJilin Province Cancer Hospital
Aug 16, 2022
Epithelial Ovarian Cancer Trial in Shanghai (LCAR-M23 cells)
Terminated
- Epithelial Ovarian Cancer
- LCAR-M23 cells
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Aug 15, 2022
Bladder Cancer Trial in Shanghai (General Anesthesia, Spinal Anesthesia)
Not yet recruiting
- Bladder Cancer
- General Anesthesia
- Spinal Anesthesia
-
Shanghai, Shanghai, ChinaRenji Hospital affliated to Shanghai Jiaotong University School
Apr 22, 2023
Head Neck Cancer, Xerostomia Trial in Madison (MSC)
Not yet recruiting
- Head and Neck Cancer
- Xerostomia
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Apr 21, 2023
Colorectal Cancer, Adenoma Trial in Oslo (A 1 Intervention arm Flex Sig, A 2 Intervention arm Flex Sig + iFOBT)
Active, not recruiting
- Colorectal Cancer
- Adenoma
- A 1 Intervention arm Flex Sig
- A 2 Intervention arm Flex Sig + iFOBT
-
Oslo, NorwayInstitute of Population-based Cancer Research
Apr 6, 2022
NSCLC Trial in Tianjin (Ensartinib, Placebo)
Recruiting
- Non-small Cell Lung Cancer
- Ensartinib
- Placebo
-
Tianjin, ChinaTianJin Medical University Cancer Institute & Hospital
Jul 13, 2022
Breast Cancer Trial in Tianjin (SHR6390+anatrozole)
Recruiting
- Breast Cancer
-
Tianjin, ChinaTianJin Medical University Cancer Institute and Hospital
Apr 6, 2022
Radiomics Based Multimodal Transvaginal Ultrasound Imaging in
Active, not recruiting
- Endometrial Cancer
- +2 more
- radiomics
-
Wuhan, Hubei, ChinaTongji Hospital of Tongji Medical College, Huazhong University o
May 18, 2022
HER2 Low and Describe SoC, Treatment Patterns, and Outcome in
Completed
- Breast Cancer
- None (Observational study)
-
Pittsburgh, Pennsylvania
- +12 more
May 25, 2022
Cancer of Unknown Primary Site Trial in Houston (Sintilimab)
Recruiting
- Cancer of Unknown Primary Site
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine
Active, not recruiting
- Chronic Hepatitis
- Hepatitis C Infection
- Electroporation-Mediated Plasmid DNA Vaccine Therapy
- +4 more
-
Jacksonville, Florida
- +4 more
Sep 20, 2022
Mastectomy; Lymphedema Trial in United States (Cryoneurolysis, Sham Comparator)
Enrolling by invitation
- Mastectomy; Lymphedema
- Cryoneurolysis
- Sham Comparator
-
Los Angeles, California
- +5 more
Dec 12, 2022
Urinary Bladder Tumors Trial in Xi'an (drug, procedure, radiation)
Not yet recruiting
- Urinary Bladder Neoplasms
- Tislelizumab Injection
- +2 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Dec 26, 2022
Pancreatic Cancer, Surgery, Laparoscopy Trial in China (Laparoscopic distal pancreatectomy, Open distal pancreatectomy)
Recruiting
- Pancreatic Cancer
- +2 more
- Laparoscopic distal pancreatectomy
- Open distal pancreatectomy
-
Hefei, Anhui, China
- +10 more
Jun 19, 2022
Colon Cancer Trial in San Antonio (PalloV-CC)
Recruiting
- Colon Cancer
- PalloV-CC
-
San Antonio, TexasClinical Associates of Research Therapeutics of America
Sep 14, 2022
Gynecology Trial in Houston (drug, other, procedure, behavioral)
Active, not recruiting
- Gynecology
- Metformin
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 14, 2022
Malignant Tumor of Breast Trial in Japan (DS-8201a)
Completed
- Malignant Neoplasm of Breast
-
Yokohama, Kanagawa, Japan
- +6 more
Mar 17, 2022